For: | Sakai N, Clarke CN, Schuster R, Blanchard J, Tevar AD, Edwards MJ, Lentsch AB. Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes. World J Gastroenterol 2010; 16(30): 3816-3826 [PMID: 20698045 DOI: 10.3748/wjg.v16.i30.3816] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i30/3816.htm |
Number | Citing Articles |
1 |
Jens Sperling, Christian Ziemann, Anika Gittler, Anna Benz-Weißer, Michael D. Menger, Otto Kollmar. Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation. Clinical & Experimental Metastasis 2015; 32(4): 313 doi: 10.1007/s10585-015-9707-4
|
2 |
Chetana Lim, Francois Cauchy, Daniel Azoulay, Olivier Farges, Maxime Ronot, Marc Pocard. Tumour progression and liver regeneration—insights from animal models. Nature Reviews Gastroenterology & Hepatology 2013; 10(8): 452 doi: 10.1038/nrgastro.2013.55
|
3 |
Yume MINAGAWA, Yohei OTA, Yuko TAMURA, Taichi YABUNO, Masazumi TAKAHASHI, Yasuhisa MOCHIZUKI, Kyoko ONO. A Case Report of Primary Buttock Angiosarcoma with Lung and Liver Metastases with a Dismal Prognosis. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2021; 82(10): 1898 doi: 10.3919/jjsa.82.1898
|
4 |
Patryk Kambakamba, Michael Linecker, Marcel Schneider, Cäcilia S. Reiner, Thi Dan Linh Nguyen-Kim, Perparim Limani, Ivan Romic, Joan Figueras, Henrik Petrowsky, Pierre-Alain Clavien, Mickaël Lesurtel. Impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on growth of colorectal liver metastases. Surgery 2018; 163(2): 311 doi: 10.1016/j.surg.2017.10.036
|
5 |
C. Lim, O. Farges. Embolisation portale avant hépatectomie majeure pour métastases hépatiques d’origine colorectale : rationnel, indications, techniques, complications et résultats. Journal de Chirurgie Viscérale 2012; 149(2): 94 doi: 10.1016/j.jchirv.2012.01.013
|
6 |
C. Lim, O. Farges. Portal vein occlusion before major hepatectomy in patients with colorectal liver metastases: Rationale, indications, technical aspects, complications and outcome. Journal of Visceral Surgery 2012; 149(2): e86 doi: 10.1016/j.jviscsurg.2012.03.003
|
7 |
Sebastian Senger, Jens Sperling, Barbara Oberkircher, Martin K. Schilling, Otto Kollmar, Michael D. Menger, Christian Ziemann. Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth. Clinical & Experimental Metastasis 2017; 34(5): 323 doi: 10.1007/s10585-017-9852-z
|
8 |
Keiichi Shirasaki, Keiko Taguchi, Michiaki Unno, Hozumi Motohashi, Masayuki Yamamoto. NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice. Hepatology 2014; 59(6): 2371 doi: 10.1002/hep.27020
|
9 |
Floor Huisman, Krijn P. van Lienden, Samantha Damude, Lisette T. Hoekstra, Thomas M. van Gulik. A review of animal models for portal vein embolization. Journal of Surgical Research 2014; 191(1): 179 doi: 10.1016/j.jss.2014.05.089
|
10 |
Ru-hai Zou, An-hua Li, Feng Han, Jian Hong, Bin-kui Li, Wei Huang, Liang Huang, Yun-fei Yuan. Liver hypertrophy and accelerated growth of implanted tumors in nonembolized liver of rabbit after left portal vein embolization. Journal of Surgical Research 2012; 178(1): 255 doi: 10.1016/j.jss.2012.02.002
|
11 |
RUI XU, YU-FENG YUAN, AHMET AYAV, CHONG-QING JIANG, LAURENT BRESLER, ZHI-SU LIU, NGUYEN TRAN. Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes. Experimental and Therapeutic Medicine 2014; 7(5): 1089 doi: 10.3892/etm.2014.1607
|
12 |
Ruifeng Wang, Zhen Quan, Tongsen Zheng, Kai Wang, Yang Liu, Zhaoguo Han, Xiance Wang, Shiling Ma, Lianxin Liu, Wan Yee Lau, Xilin Sun. Pathophysiological mechanisms of ALPPS: experimental model. British Journal of Surgery 2022; 109(6): 510 doi: 10.1093/bjs/znac007
|
13 |
Weizheng Ren, Aiqun Zhang, Jiahong Dong. Integrating repopulation and regeneration of the auxiliarily transplanted small liver graft: The solution for organ shortage and immunosuppression. Medical Hypotheses 2012; 79(2): 241 doi: 10.1016/j.mehy.2012.04.048
|